Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Tanizawa

Showing results (51-60 of 69) with videos related to

Pageof 7
Sort By:
Clinical Nephrology|July 1, 1989
Long-term follow-up of membranoproliferative glomerulonephritis type II and pregnancy: a case reportS Inaba, T Tanizawa, T Igarashi, et al.
Leukemia|February 3, 1998
Overexpression of tumor necrosis factor (TNF)-alpha and interferon (IFN)-gamma by bone marrow cells from patients with myelodysplastic syndromesM Kitagawa, I Saito, T Kuwata, et al.
American Journal of Nephrology|October 31, 2001
Influence of prolonged corticosteroid therapy on the outcome of steroid-responsive nephrotic syndromeH Matsukura, S Inaba, K Shinozaki, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 1, 1996
Changes in biological activity of bone cells in ovariectomized rats revealed by in situ hybridizationT Ikeda, A Yamaguchi, S Yokose, et al.
American Journal of Clinical Pathology|December 1, 1986
Glomerulonephritis with focal and segmental distribution of glomerular basement membrane antigen(s)M Hara, R Asada, I K Miura, et al.
Clinical Nephrology|April 1, 1996
Decrease of mesangial matrix after immunosuppressive therapy in children with reversible membranoproliferative glomerulonephritis type IS Inaba, T Tanizawa, T Takahashi, et al.
Bone|November 1, 1994
Increased bone formation by intermittent parathyroid hormone administration is due to the stimulation of proliferation and differentiation of osteoprogenitor cells in bone marrowS Nishida, A Yamaguchi, T Tanizawa, et al.
Nihon Jinzo Gakkai Shi|April 1, 1986
[The effectiveness of cocktail therapy in the early treatment of children with MPGN type I, with special regard to remarkable histological improvement]T Tanizawa, K Miura, R Asada, et al.
European Journal of Pediatrics|September 1, 1985
Chlorambucil central nervous toxicity: a significant side effect of chlorambucil therapy in childhood nephrotic syndromeF Ichida, T Konishi, R Asada, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|March 18, 2014
Incidence of pneumothorax in advanced and/or metastatic soft tissue sarcoma patients during pazopanib treatmentK Nakano, L Inagaki, J Tomomatsu, et al.
Pageof 7

Showing results (51-60 of 69) with videos related to

Sort By:
Pageof 7
Clinical Nephrology|July 1, 1989
Long-term follow-up of membranoproliferative glomerulonephritis type II and pregnancy: a case reportS Inaba, T Tanizawa, T Igarashi, et al.
Leukemia|February 3, 1998
Overexpression of tumor necrosis factor (TNF)-alpha and interferon (IFN)-gamma by bone marrow cells from patients with myelodysplastic syndromesM Kitagawa, I Saito, T Kuwata, et al.
American Journal of Nephrology|October 31, 2001
Influence of prolonged corticosteroid therapy on the outcome of steroid-responsive nephrotic syndromeH Matsukura, S Inaba, K Shinozaki, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 1, 1996
Changes in biological activity of bone cells in ovariectomized rats revealed by in situ hybridizationT Ikeda, A Yamaguchi, S Yokose, et al.
American Journal of Clinical Pathology|December 1, 1986
Glomerulonephritis with focal and segmental distribution of glomerular basement membrane antigen(s)M Hara, R Asada, I K Miura, et al.
Clinical Nephrology|April 1, 1996
Decrease of mesangial matrix after immunosuppressive therapy in children with reversible membranoproliferative glomerulonephritis type IS Inaba, T Tanizawa, T Takahashi, et al.
Bone|November 1, 1994
Increased bone formation by intermittent parathyroid hormone administration is due to the stimulation of proliferation and differentiation of osteoprogenitor cells in bone marrowS Nishida, A Yamaguchi, T Tanizawa, et al.
Nihon Jinzo Gakkai Shi|April 1, 1986
[The effectiveness of cocktail therapy in the early treatment of children with MPGN type I, with special regard to remarkable histological improvement]T Tanizawa, K Miura, R Asada, et al.
European Journal of Pediatrics|September 1, 1985
Chlorambucil central nervous toxicity: a significant side effect of chlorambucil therapy in childhood nephrotic syndromeF Ichida, T Konishi, R Asada, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|March 18, 2014
Incidence of pneumothorax in advanced and/or metastatic soft tissue sarcoma patients during pazopanib treatmentK Nakano, L Inagaki, J Tomomatsu, et al.
Pageof 7